Medical and Pharmaceutical Industry - Market Research Report

The   China in vitro diagnostics (IVD) market   was valued at USD 5.5 billion in 2023 and is projected to grow steadily through 2030. This expansion is supported by rising prevalence of chronic and infectious diseases including diabetes, cancer, tuberculosis, and other communicable conditions, as well as increasing healthcare investment and demand for early diagnostic testing. Testing technologies, especially those enabling rapid and accurate detection, have become more essential following the COVID-19 pandemic, which significantly accelerated the adoption of diagnostic solutions for disease surveillance and population health management. Government healthcare initiatives focusing on preventive care and diagnostic accessibility continue to stimulate demand, particularly among the aging population. Innovation and commercialization efforts by international and domestic companies are also contributing to broader market penetration and technological advancement. The market’s struct...

The global   cell therapy technologies market   was valued at USD 6.54 billion in 2024 and is projected to reach USD 17.46 billion by 2030, expanding at a CAGR of 17.84% from 2025 to 2030. The market is witnessing robust growth, primarily driven by rapid advancements in personalized medicine, increasing adoption of cell-based therapies, and substantial investments from leading pharmaceutical and biotechnology companies. Key Market Trends & Insights North America dominated the global market, accounting for a 40.32% share in 2024. By product, the consumables segment led the market with a 42.70% share in 2024. By workflow, the separation segment held the largest share at 34.55% in 2024. By cell type, T-cells emerged as the dominant segment, capturing 57.49% of the market in 2024. By end use, biopharmaceutical and pharmaceutical companies accounted for the highest share of 53.23% in 2024. Market Size & CAGR 2024 Market Size: USD 6.54 Billion 2030 Projected Market Size: USD...

The global   cell expansion market   was valued at USD 17.75 billion in 2022 and is anticipated to reach USD 47.13 billion by 2030, registering a compound annual growth rate (CAGR) of 12.85% from 2023 to 2030. Market growth is primarily driven by the increasing adoption of automated solutions across cell expansion applications, which enhance scalability, consistency, and operational efficiency. Automation in cell expansion significantly reduces manual labor requirements and operational costs associated with the production of Cell Therapy Products (CTPs), gene therapies, and other biologics. These systems enable more robust, reproducible, and reliable manufacturing workflows, supporting the growing demand for advanced cell-based therapies. Key Market Trends & Insights North America dominated the global market in 2022, accounting for 39.0% of total revenue, supported by strong biopharmaceutical infrastructure and high adoption of advanced technologies. By product, consumable...

The global   cell culture vessels market   was valued at USD 4.83 billion in 2025 and is expected to expand significantly, reaching USD 13.77 billion by 2033. This growth represents a robust CAGR of 14.4% during the forecast period from 2026 to 2033. Market expansion is primarily driven by the rising prevalence of chronic diseases, increasing investments in research and development, and a growing number of clinical trials focused on cell-based and advanced therapies. The escalating adoption of cell culture technologies across biopharmaceutical research, regenerative medicine, and drug discovery continues to strengthen demand for reliable, scalable, and contamination-free culture vessels. Key Market Trends & Insights North America dominated the global cell culture vessels market with a 36.42% share in 2025. The U.S. cell culture vessels market is anticipated to witness strong growth throughout the forecast period. By product, the bags segment accounted for the largest marke...

The global   cell culture market   was valued at USD 20.47 billion in 2024 and is projected to reach USD 53.17 billion by 2033, expanding at a CAGR of 11.21% from 2025 to 2033. This robust growth is primarily driven by the escalating demand for biopharmaceuticals, the increasing use of cell-based assays in drug discovery, and continuous technological advancements in cell culture systems. Cell culture has evolved from a basic research tool into a foundational technology across multiple scientific and industrial applications. It now plays a critical role in toxicology testing, vaccine development, regenerative medicine, and large-scale biopharmaceutical manufacturing. Enhanced control over cellular environments has significantly improved experimental reproducibility and operational efficiency. Furthermore, innovations such as serum-free and chemically defined media have enabled higher product yields and purity levels, accelerating adoption across both academic research and comme...

The global   body contouring devices market   was valued at USD 1.50 billion in 2023 and is expected to expand significantly, reaching USD 3.86 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 14.3% over the forecast period from 2024 to 2030. Body contouring devices are designed to reshape specific areas of the body and include invasive, minimally invasive, and non-invasive solutions aimed at fat reduction and skin firming. Body contouring procedures may be performed surgically through techniques such as liposuction or via less invasive approaches, including cryolipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis. These procedures primarily focus on eliminating unwanted fat deposits while improving firmness and contour in targeted treatment areas. Key Market Trends and Insights North America dominated the global body contouring devices market in 2023, accounting for a revenue share of 35.2%. The Asia Pacific region is an...

The global   biosurgery market   was valued at USD 25.69 billion in 2023 and is expected to reach USD 35.85 billion by 2030, expanding at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2030. Market growth is primarily driven by the rising preference for minimally invasive surgical procedures, along with continuous advancements in healthcare-related scientific technologies. Biosurgery involves the use of biomaterials rather than synthetic alternatives during surgical procedures to support tissue reconstruction, improve surgical outcomes, accelerate patient recovery, and promote tissue regeneration. The growing demand for such procedures is reinforcing the adoption of biosurgical products across multiple medical disciplines. Key Market Trends & Insights North America accounted for the largest revenue share of 50.1% in 2023, maintaining its dominant market position. Asia Pacific is projected to register the fastest CAGR of 6.0% during the forecast period. By produc...

The global   biopsy devices market   was valued at USD 2.25 billion in 2023 and is projected to reach USD 3.64 billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030. Market growth is primarily driven by the rising global burden of cancer, increasing adoption of minimally invasive diagnostic procedures, expanding healthcare infrastructure, and significant untapped opportunities in emerging economies, particularly across the Asia Pacific region. The growing focus on early and accurate disease diagnosis, coupled with technological advancements in biopsy procedures, continues to strengthen demand for advanced biopsy devices worldwide. Key Market Trends & Insights North America dominated the global biopsy devices market, accounting for 43.1% of total revenue in 2023. The U.S. biopsy devices market held a significant 34.6% share of the global market in 2023. By product, needle-based biopsy guns led the market with a revenue share of 43.1% in 2023. The biopsy needle segm...

The global   wearable injectors market   was valued at USD 8.80 billion in 2023 and is projected to reach USD 23.89 billion by 2030, expanding at a compound annual growth rate (CAGR) of 18.11% from 2024 to 2030. Market growth is primarily driven by the increasing prevalence of chronic diseases, a rapidly aging global population, and heightened awareness regarding the prevention of needle stick injuries among healthcare professionals. Wearable injectors are gaining traction as a cost-effective and patient-centric alternative to conventional drug delivery methods. The rising emphasis on reducing overall healthcare expenditures, coupled with growing demand for home-based care and continuous drug delivery, is expected to further accelerate market adoption. Key Market Trends and Insights North America emerged as the leading regional market, accounting for 33.2% of global revenue in 2023, supported by advanced healthcare infrastructure and high adoption of innovative drug delivery t...

The global   transplant diagnostics market   was valued at USD 6.39 billion in 2024 and is projected to reach USD 12.15 billion by 2033, expanding at a CAGR of 7.45% from 2025 to 2033. Market growth is primarily supported by the rising prevalence of genetic and chronic disorders, continuous advancements in genetic and molecular testing technologies, and increasing adoption of personalized medicine approaches in transplantation care. Transplant diagnostics play a critical role in ensuring donor–recipient compatibility, minimizing organ rejection risks, and improving post-transplant outcomes. Growing awareness among healthcare providers and patients regarding the importance of precise diagnostic testing continues to accelerate market demand globally. Key Market Trends & Insights North America accounted for the largest global revenue share of 32.52% in 2024 The U.S. led the North American market with the highest revenue contribution in 2024 By test type, the molecular assays ...

The global   synthetic biology market   was valued at USD 16.2 billion in 2024 and is expected to expand significantly, reaching USD 42.06 billion by 2030. This growth reflects a robust CAGR of 17.30% from 2025 to 2030. Rising adoption of synthetic biology across advanced applications such as multiplexed diagnostics, cellular recording, and therapeutic genome editing is driving strong demand for synthetic products throughout the forecast period. Expanding use cases across healthcare, industrial biotechnology, and research environments continue to accelerate market momentum. In parallel, increasing investments in next-generation biological tools and platforms are strengthening the commercial viability of synthetic biology solutions worldwide. Key Market Trends & Insights North America accounted for the largest market share of 41.98% in 2024, supported by strong R&D infrastructure and early technology adoption. Asia Pacific is anticipated to register the fastest growth, ...

The global   surgical robotic services market   was valued at USD 1.53 billion in 2023 and is expected to reach USD 3.73 billion by 2030, expanding at a CAGR of 13.9% from 2024 to 2030. Market growth is primarily driven by the increasing adoption of robotic technologies in surgical procedures, the growing need for specialized surgical expertise, rising demand for remote monitoring and telesurgery services, and the shift toward cost-effective service-based operating models. Additional growth momentum is supported by a shorter learning curve for robotic systems, reduced training complexity, and increasing government investments and funding initiatives worldwide. However, high initial setup costs and ongoing maintenance expenses continue to restrain adoption, particularly among small and mid-sized healthcare facilities. Addressing affordability and long-term cost efficiency will be critical to accelerating broader market penetration. Key Market Trends & Insights North America...